HemostOD

The Lausanne hematology research community celebrates four awards in the Swiss Oncology and Hematology Conference!!! Best abstract award on its categories for Tiffany Que (experimental hematology/oncology, Caroline Arber Barth lab) and for Magali Humbert (hemostasis, transfusion medicine and benign hematology, HemostOD, collaboration with Olaia Naveiras lab). Jacques and Gloria Gossweiler 2024 Fellowship award for Maxime Zermatten (Lorenzo ALBERIO lab) and the 2024 Ellermann award “Relève en Hématologie” for Frédérica Schyrr (Raffaele Renella and Olaia Naveiras labs). Bravo to you all!! You make your home institutions very proud Oncologie | UNIL-CHUV & FBM UNIL - Faculté de biologie et de médecine de l'Université de Lausanne. Thank you to chairs Anne Angelillo-Scherrer and Andre Tichelli for making it possible!!

We’re proud to announce the formation of our Scientific Advisory Board, a major milestone in our journey to revolutionize platelet development for transfusion. This diverse, global team of leading experts in hematology, cell therapy, and biotechnology will be instrumental in accelerating our mission to provide safe, scalable, and innovative platelet solutions for patients in need. We are honored to welcome: Prof. Terry Gernsheimer, MD – Hematology & platelet transfusion medicine expert Dr. Florence Salmon, PhD – Regulatory & cell therapy CMC expert Prof. Andrew L. "Larry" Frelinger III, Ph.D. – Leader in platelet biology Prof. Philippe Renaud, PhD – Microfluidics & biomedical applications expert Together, we are committed to advancing transfusion medicine and improving access to life-saving treatments worldwide. 🌍 #Innovation #TransfusionMedicine #ScientificAdvisoryBoard #Hematology #Platelets

We’re proud to announce the formation of our Scientific Advisory Board, a major milestone in our journey to revolutionize platelet development for transfusion. This diverse, global team of leading experts in hematology, cell therapy, and biotechnology will be instrumental in accelerating our mission to provide safe, scalable, and innovative platelet solutions for patients in need. We are honored to welcome: Prof. Terry Gernsheimer, MD – Hematology & platelet transfusion medicine expert Dr. Florence Salmon, PhD – Regulatory & cell therapy CMC expert Prof. Andrew L. "Larry" Frelinger III, Ph.D. – Leader in platelet biology Prof. Philippe Renaud, PhD – Microfluidics & biomedical applications expert Together, we are committed to advancing transfusion medicine and improving access to life-saving treatments worldwide. 🌍 #Innovation #TransfusionMedicine #ScientificAdvisoryBoard #Hematology #Platelets

We're #hiring a new Head of Biology with expertise in hemostasis in Lausanne Metropolitan Area. Apply today or share this post with your network.

We’re #hiring. Know anyone who might be interested?

HemostOD was interviewed (in French) about our technology on the Swiss national radio-TV RTS - Radio Télévision Suisse . #platelets #startup #Switzerland #innovation #transfusion https://lnkd.in/epA38MNz

Une interview de notre technologie à la radio nationale suisse

HemostOD and Emissium get FIT boost 🚀 🚀 🇨🇭 🌐 The FIT - Fondation pour l'Innovation Technologique is awarding two loans to two EPFL startups: HemostOD and its innovative solution for producing blood platelets rapidly and on a large scale, and to Emissium and its software that enables users to monitor, improve and reduce their electricity-related emissions. The former is receiving a Tech Growth loan of CHF 500,000, the latter a Tech Seed loan of CHF 100,000. All our congratulations go to CEOs Faouzi Khechana (HemostOD) and Rafael Castro-Amoedo (Emissium) and their respective teams for this funding milestone achievement! 👏 👏 Keep on rocking! Learn more about the two companies and their plans with this article: https://bit.ly/4elcWL9 Have a nice day, keep on innovating and stay healthy! #Swisstech #VDtech #startupfit #biotech #sustainability #funding Aurélie Schick Julie Bocquel EPFL Startup

HemostOD receives the support of the FIT - Fondation pour l'Innovation Technologique in the form of a CHF 500'000 Tech Growth loan. This will significantly help advance our current developments in ex vivo platelet manufacturing!

HemostOD is featured today in the news! Retrouvez HemostOD dans le journal 24 heures aujourd'hui ! #platelets #transfusion #blood #startup #swiss #Switzerland #Vaud #Lausanne